Jianbing Zhang

Jianbing Zhang has extensive experience in the pharmaceutical industry, particularly in analytical development and quality control. Jianbing has held various senior positions, including Senior Director of Analytical Development and Stability at Kura Oncology, Inc., Director of Analytical Development at Acadia Pharmaceuticals Inc., TG Therapeutics, Inc., and Lexicon Pharmaceuticals, Inc., and Fellow/Analytical Project Leader at Novartis. Jianbing has managed analytical activities at contract laboratories, supported process development and optimization, and authored and reviewed technical documents and SOPs. Jianbing has also provided technical support to customers, synthesis labs, and formulation development labs. Additionally, Jianbing has experience in project management, including strategic planning, timeline management, and cost control. Jianbing has supervised and provided guidance to junior scientists and demonstrated strong leadership skills throughout their career.

Jianbing Zhang holds a Bachelor of Science degree in Chemistry from the University of Science and Technology of China. Jianbing also obtained a Master of Science degree in Computer Science from Rutgers University. Additionally, they completed a Ph.D in Chemistry at Rutgers University as well.